Skip to content
Home » Arrowhead Research Corporation (ARWR) Q4 2014 Results Earnings Call Transcript

Arrowhead Research Corporation (ARWR) Q4 2014 Results Earnings Call Transcript

Edited Transcript of Arrowhead Research Corporation (ARWR) Q4 2014 Earnings Conference Call…

Arrowhead Research Corporation (NASDAQ:ARWR)hosted a conference call with investors and analysts to discuss Q4 2014 earnings results on November 25, 2014 at 4:30 p.m. ET. The following are the webcast audio and the associated transcript of the event…

Operator: Ladies and gentlemen, welcome to the Arrowhead Research fiscal 2014 fourth quarter year end financial results conference call. Throughout today’s recorded presentation all participants will be in a listen-only mode. After the presentation, there will be an opportunity to ask questions.

I will now hand the conference call over to Vincent Anzalone, Vice President of Investor Relations for Arrowhead. Please go ahead, Vince.

Vince Anzalone – VP, IR

Thank you. Good afternoon everyone. And thank you for joining us today to discuss Arrowhead’s results for its fiscal 2014 fourth quarter and year ended September 30, 2014.

With us today from management are President and CEO, Dr. Christopher Anzalone; Chief Operating Officer and Head of R&D, Dr. Bruce Given; Chief Financial Officer, Ken Myszkowski. Management will provide a brief overview of the quarter and we’ll then open up the call to your questions.

Before we begin, I would like to remind you that comments made during today’s call may contain certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934.

All statements other than statements of historical facts, including without limitation those with respect to Arrowhead’s goals, plans and strategies, are forward-looking statements. These include but are not limited to statements regarding the anticipated safety and or efficacy of ARC-520 and our other clinical programs, as well as anticipated timing for study enrollment and completion, it represent management’s current expectations and are inherently uncertain. Thus actual results may differ materially.

Arrowhead undertakes no duty to update any of the forward-looking statements discussed on today’s call. You should refer to the discussions under Risk Factors in Arrowhead’s annual report on Form 10-K and the company’s quarterly reports on Form 10-Q for additional matters to be considered in this regard.

Pages: First |1 | ... | Next → | Last | View Full Transcript